Brief: Herantis Pharma Gets Approval Of Clinical Trial Application For Phase 1B Trial

Herantis Pharma Oyj

03/09/2024 09:50

Sept 3 (Reuters) - Herantis Pharma Oyj  HRTIS.HE :
    * APPROVAL OF CLINICAL TRIAL APPLICATION FOR PHASE 1B TRIAL
WITH
HER-096 IN PARKINSON’S DISEASE

Source text for Eikon:  ID: 
Further company coverage:  HRTIS.HE 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))